[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet. Public …, 2020 - europepmc.org
BACKGROUND: Funding for human papillomavirus (HPV) vaccination in Japan began in
2010 for girls aged 12-16 years, with three-dose coverage initially reaching more than 70 …
2010 for girls aged 12-16 years, with three-dose coverage initially reaching more than 70 …
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith… - The Lancet Public …, 2020 - abdn.elsevierpure.com
BACKGROUND: Funding for human papillomavirus (HPV) vaccination in Japan began in
2010 for girls aged 12-16 years, with three-dose coverage initially reaching more than 70 …
2010 for girls aged 12-16 years, with three-dose coverage initially reaching more than 70 …
[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - Elsevier
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
[引用][C] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - cir.nii.ac.jp
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - thelancet.com
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
[PDF][PDF] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane… - The Lancet Public …, 2020 - aura.abdn.ac.uk
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
[PDF][PDF] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane, K Canfell - 2020 - researchgate.net
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
[PDF][PDF] Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith, A Keane, K Canfell - Lancet, 2020 - researchmap.jp
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12–16 years, with three-dose coverage initially reaching more than 70%. On …
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
KT Simms, SJB Hanley, MA Smith… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Funding for human papillomavirus (HPV) vaccination in Japan began in 2010
for girls aged 12-16 years, with three-dose coverage initially reaching more than 70%. On …
for girls aged 12-16 years, with three-dose coverage initially reaching more than 70%. On …